Bonds
Below is the list of AstraZeneca PLC ADR corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
|---|---|---|---|---|---|---|---|---|---|
| 12.21% | 0 | 99.92% | 3.375% | 2025-11-16 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 5.26% | 0 | 88.25% | 4.375% | 2048-08-17 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 5.25% | 0 | 89.16% | 4.375% | 2045-11-16 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 5.25% | 0 | 68.48% | 3.000% | 2051-05-28 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 5.23% | 0 | 57.14% | 2.125% | 2050-08-06 | 500 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 5.14% | 24 K | 87.23% | 4.000% | 2042-09-18 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 4.82% | 277 K | 114.53% | 6.450% | 2037-09-15 | 2.75 B USD | 1,000.00 USD | 1,000.00 USD | AstraZeneca PLC | |
| UUS4636NAN3AstraZeneca Finance LLC 5.0% 26-FEB-2034 | 4.51% | 0 | 103.29% | 5.000% | 2034-02-26 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| AAZN5549116AstraZeneca Finance LLC 4.875% 03-MAR-2033 | 4.35% | 1.04 M | 103.23% | 4.875% | 2033-03-03 | 500 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| UUS4636NAA1AstraZeneca Finance LLC 1.2% 28-MAY-2026 | 4.24% | 0 | 98.40% | 1.200% | 2026-05-28 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| UUS4636NAM5AstraZeneca Finance LLC 4.9% 26-FEB-2031 | 4.21% | 0 | 103.22% | 4.900% | 2031-02-26 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| 4.20% | 0 | 108.05% | 5.750% | 2031-11-13 | 350 M GBP | 1,000.00 GBP | 50,000.00 GBP | AstraZeneca PLC | |
| 4.17% | 0 | 98.63% | 0.700% | 2026-04-08 | 1.2 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| AAZN5193314AstraZeneca Finance LLC 2.25% 28-MAY-2031 | 4.10% | 260 K | 90.90% | 2.250% | 2031-05-28 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| 4.08% | 0 | 88.46% | 1.375% | 2030-08-06 | 1.3 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| AAZN5549115AstraZeneca Finance LLC 4.9% 03-MAR-2030 | 4.07% | 60 K | 103.22% | 4.900% | 2030-03-03 | 650 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| UUS4636NAL7AstraZeneca Finance LLC 4.85% 26-FEB-2029 | 4.01% | 0 | 102.53% | 4.850% | 2029-02-26 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| UUS4636NAK9AstraZeneca Finance LLC 4.8% 26-FEB-2027 | 4.00% | 0 | 100.98% | 4.800% | 2027-02-26 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| 3.98% | 0 | 100.06% | 4.000% | 2029-01-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| 3.90% | 0 | 98.82% | 3.125% | 2027-06-12 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca PLC | |
| AAZN5549114AstraZeneca Finance LLC 4.875% 03-MAR-2028 | 3.84% | 445 K | 102.26% | 4.875% | 2028-03-03 | 1.1 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| AAZN5193317AstraZeneca Finance LLC 1.75% 28-MAY-2028 | 3.78% | 10.04 M | 95.12% | 1.750% | 2028-05-28 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AstraZeneca Finance LLC |
| XXS287290977AstraZeneca Finance LLC 3.278% 05-AUG-2033 | 3.21% | 0 | 100.46% | 3.278% | 2033-08-05 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca Finance LLC |
| 3.01% | 0 | 104.19% | 3.750% | 2032-03-03 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca PLC | |
| XXS287290969AstraZeneca Finance LLC 3.121% 05-AUG-2030 | 2.80% | 0 | 101.40% | 3.121% | 2030-08-05 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca Finance LLC |
| 2.67% | 0 | 92.29% | 0.375% | 2029-06-03 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca PLC | |
| 2.38% | 0 | 101.57% | 3.625% | 2027-03-03 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca PLC | |
| 2.36% | 0 | 97.34% | 1.250% | 2028-05-12 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | AstraZeneca PLC |